» Authors » Lucas S Shores

Lucas S Shores

Explore the profile of Lucas S Shores including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 112
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao S, Budina E, Raczy M, Solanki A, Nguyen M, Beckman T, et al.
Nat Biomed Eng . 2024 Apr; 8(5):611-627. PMID: 38561491
Butyrate-a metabolite produced by commensal bacteria-has been extensively studied for its immunomodulatory effects on immune cells, including regulatory T cells, macrophages and dendritic cells. However, the development of butyrate as...
2.
Kelly S, Votaw N, Cossette B, Wu Y, Shetty S, Shores L, et al.
Sci Adv . 2022 Nov; 8(47):eabq4120. PMID: 36417519
Urinary tract infections (UTIs) are a major public health problem affecting millions of individuals each year. Recurrent UTIs are managed by long-term antibiotic use, making the alarming rise of antibiotic...
3.
Majumdar S, Wang X, Sommerfeld S, Chae J, Athanasopoulou E, Shores L, et al.
Adv Funct Mater . 2021 Sep; 28(41). PMID: 34531709
Collagen-rich tissues in the cornea exhibit unique and highly organized extracellular matrix ultrastructures, which contribute to its high load-bearing capacity and light transmittance. Corneal collagen fibrils are controlled during development...
4.
Hainline K, Shores L, Votaw N, Bernstein Z, Kelly S, Fries C, et al.
Proc Natl Acad Sci U S A . 2021 Apr; 118(15). PMID: 33876753
Complement protein C3dg, a key linkage between innate and adaptive immunity, is capable of stimulating both humoral and cell-mediated immune responses, leading to considerable interest in its use as a...
5.
Shores L, Kelly S, Hainline K, Suwanpradid J, MacLeod A, Collier J
Front Immunol . 2020 Sep; 11:1855. PMID: 32973764
Current treatments for chronic immune-mediated diseases such as psoriasis, rheumatoid arthritis, or Crohn's disease commonly rely on cytokine neutralization using monoclonal antibodies; however, such approaches have drawbacks. Frequent repeated dosing...
6.
Si Y, Tian Q, Zhao F, Kelly S, Shores L, Camacho D, et al.
Sci Adv . 2020 Aug; 6(32):eaba0995. PMID: 32821819
The current paradigm that subunit vaccines require adjuvants to optimally activate innate immunity implies that increased vaccine reactogenicity will invariably be linked to improved immunogenicity. Countering this paradigm, nanoparticulate vaccines...
7.
Kelly S, Shores L, Votaw N, Collier J
Adv Drug Deliv Rev . 2017 Apr; 114:3-18. PMID: 28455189
Biomaterials employed to raise therapeutic immune responses have become a complex and active field. Historically, vaccines have been developed primarily to fight infectious diseases, but recent years have seen the...
8.
Yang S, Guo Q, Shores L, Aly A, Ramakrishnan M, Kim G, et al.
J Biomed Mater Res A . 2014 Mar; 103(1):235-42. PMID: 24616321
Replacement of autogenous or allograft bones by artificial graft materials represents a growing area of interest in current bone repair strategies. Bioactive ceramics in particulate form, such as Bioglass (BG)...